PHE Reproductive Health, Sexual Health and HIV Innovation Fund
(asked on 8th January 2024) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the findings were of the independent review of the impact of the Sexual Health, Reproductive Health and HIV Innovation Fund.
The Reproductive Health, Sexual Health and HIV Innovation Fund is a competitive grant scheme first started by Public Health England (PHE) which aimed to encourage local innovation to reduce the impact of HIV and improve sexual and reproductive health in England, with the first four cohorts addressing HIV only. The following table outlines the funding received for the seven cohorts which have taken place since the scheme began:
Year | Funding (£) |
2015/2016 (Cohort 1) | 501,463 |
2016/2017 (Cohort 2) | 629,844 |
2017/2018 (Cohort 3) | 574,030 |
2018/2019 (Cohort 4) | 603,418 |
2019/2020 (Cohort 5) | 605,102 |
2020/2021 (Cohort 6) | 301,764 |
2021/2022 (Cohort 7) | 290,129 |
Funding was paused for 2022/2023 to allow for the publication of an independent review. In January 2023, Ipsos Mori published the findings from an overarching independent impact evaluation of the Innovation Fund which is available at the following link:
No funding was provided for 2023/2024, and a decision has not yet been made regarding funding for 2024/2025.